Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Gland Pharma Ltd

Gland Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,646.35
  • Today's Change3.55 / 0.22%
  • Shares traded20.97k
  • 1 Year change+6.86%
  • Beta0.7002
Data delayed at least 15 minutes, as of Nov 01 2024 13:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Gland Pharma Ltd (GLAND:NSI) closed at 1,646.35, 10.74% above the 52 week low of 1,486.65 set on Nov 02, 2023.
52-week range
Today
1,486.65Nov 02 20232,220.95Aug 06 2024
Open1,651.10
High1,659.45
Low1,637.45
Bid1,646.35
Offer1,651.40
Previous close1,642.80
Average volume173.58k
Shares outstanding164.75m
Free float79.34m
P/E (TTM)37.67
Market cap272.02bn INR
EPS (TTM)43.83
INR
Annual div (ADY)20.00
INR
Annual div yield (ADY)1.21%
Div ex-dateAug 16 2024
Div pay-dateSep 29 2024
Data delayed at least 15 minutes, as of Nov 01 2024 13:49 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.